Skip to main content
Signal8

Jaguar Health, Inc. (JAGX)

Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health. Presently, the company markets Mytesi, an approved medication providing symptomatic relief for noninfectious diarrhea experienced by adults with HIV/AIDS undergoing antiretroviral therapy. Beyond its commercial product, Jaguar Health is actively advancing Crofelemer, the active pharmaceutical ingredient in Mytesi, for a broad spectrum of additional indications. These include managing diarrhea associated with cancer therapy, seeking orphan drug designation for symptomatic relief in infants and children with congenital diarrheal disorders, and for adult and pediatric patients suffering from short bowel syndrome with intestinal failure. Further potential applications encompass supportive care for diarrhea linked to inflammatory bowel diseases, diarrhea-predominant irritable bowel syndrome (IBS-D), and idiopathic or functional diarrhea. Their pipeline also features lechlemer, a next-generation anti-secretory agent being developed to combat cholera. In the animal health sector, they are developing Canalevia, an oral, plant-derived drug candidate designed to address chemotherapy-induced diarrhea and exercise-induced diarrhea in canines. Established in 2013, Jaguar Health, Inc. maintains its headquarters in San Francisco, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Jaguar Health, Inc. logo

Jaguar Health, Inc.

NASDAQ:JAGXHealthcare
-1.68%$0.3799
CLOSED
AH$0.3704-2.50%vs close
Mkt Cap$5.07M
EV$47.71M
Float–
O/S13.35M
VOL542K sh
$ Vol$196K
RVOL0.63×
Inst Own0.1%
Net Cash/Sh-$3.19
Dilution
Jaguar Health, Inc. logoNASDAQ:JAGXClosed$0.3799-1.68%
Financials Summary
Revenue$11.51M
Net Income-$53.43M
Total Assets$38.32M
Free Cash Flow$5.77M
Debt & Equity
Debt 151%
Preferred 9%
Total Debt$43.61M
Total Equity-$17.29M
Preferred Stock$2.48M
Shares Outstanding
Short Interest

No short interest data available.

Split History8 splits · 8 reverse
2-year cumulative
1:13,125Over cap

Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period

  1. 1:15Reverse split
    Sep 17, 202615 shares → 1
  2. 1:35Reverse split
    Apr 30, 202635 shares → 1
  3. 1:25Reverse split
    Mar 24, 202525 shares → 1
  4. 1:60Reverse split
    May 23, 202460 shares → 1
  5. 1:75Reverse split
    Jan 23, 202375 shares → 1
  6. 1:3Reverse split
    Sep 8, 20213 shares → 1
  7. 1:70Reverse split
    Jun 7, 201970 shares → 1
  8. 1:15Reverse split
    Jun 1, 201815 shares → 1
Balance Sheet Details
Assets$38.32M
Liabilities$57.01M
Accounts Receivable$1.7M
Accounts Payable$8.69M
Inventory$8.6M
PP&E (Net)$1.46M
Goodwill$0
Intangible Assets$16.02M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue$11.51M$11.69M$9.76M$11.96M$4.33M$9.38M$5.78M$4.42M$4.36M$142K$258K$0
YoY Growth-1.5%19.8%-18.4%175.8%-53.8%62.5%30.8%1.3%2981.6%-45.2%--
Cost of Revenue$3.77M$1.96M$2.04M$2.02M$2.33M$3.28M$3.82M$2.77M$880K$52K$123K$0
Gross Profit$7.74M$9.73M$7.72M$9.94M$2M$6.11M$1.96M$1.65M$3.48M$90K$135K$0
Gross Margin67.2%83.3%79.1%83.1%46.2%65.1%33.9%37.4%79.8%63.3%52.2%-
Research and Development$24.97M$16.54M$18.6M$17.65M$15.08M$6.41M$5.82M$5.15M$4.27M$7.21M$6.48M$4.22M
Selling, General, and Administrative$26.02M$24.02M$23.05M$26.7M$26M$21M$20.44M$22.11M$14.33M$6.47M$6.1M$4.1M
Other$1.86M$0$371K$0$1.63M$5.34M$4.65M$0$89K-$11K-$27K$0
Total Operating Expenses$52.84M$40.56M$42.02M$44.35M$42.71M$32.75M$30.91M$27.26M$18.6M$13.68M$12.58M$8.32M
Operating Income (EBIT)-$45.11M-$30.83M-$34.29M-$34.41M-$40.71M-$26.65M-$28.95M-$30.82M-$34.25M-$13.59M-$12.45M-$8.32M
Operating Margin-391.9%-263.8%-351.3%-287.8%-939.1%-283.9%-501.3%-698.0%-785.3%-9599.8%-4816.7%-
Interest Expense-$67K$231K$6.38M$12.72M$8.42M$2.79M$5.73M$2.63M$1.21M$986K$3.32M$0
Interest Income$0$0$0$0$0$2.79M$0$0$0$0$0$0
Other Income (Expense)-$8.89M-$8.42M-$7.61M-$13.98M-$11.89M-$7.16M-$9.58M-$1.32M-$903K-$1.15M-$3.85M-$294K
Income Before Tax (EBT)-$54M-$39.25M-$41.9M-$48.4M-$52.6M-$33.81M-$38.53M-$32.15M-$35.15M-$14.73M-$16.29M-$8.61M
Income Tax Expense$0$0$0$0$0$0$10K$0-$13.18M$0$0$0
Net Income-$53.43M-$38.49M-$41.3M-$47.45M-$52.59M-$33.81M-$38.54M-$32.15M-$21.97M-$14.73M-$16.29M-$8.61M
Net Income Margin-464.2%-329.3%-423.1%-396.9%-1213.3%-360.2%-667.3%-727.9%-503.7%-10410.9%-6305.2%-
Supplementary Data
EPS-12059.25-68611.05-1409880.00-28492920.00-69476385.00-177212295.00-1596051840.00-27158254770.00-94883906280.00-251163281340.00-502326562680.00-375814687635.00
Diluted EPS-12059.25-68611.05-1409880.00-28492920.00-69476385.00-177212295.00-1596051840.00-27158254770.00-94883906280.00-251163281340.00-502326562680.00-375814687635.00
Weighted Average OS4,443561291.6650.7570.218000000
EBITDA-$51.73M-$36.66M-$31.53M-$33.38M-$42.37M-$28.74M-$30.87M-$28.2M-$11.13M-$13.7M-$12.97M-$8.26M
EBITDA Margin-449.4%-313.6%-323.0%-279.2%-977.3%-306.2%-534.5%-638.5%-255.2%-9680.9%-5019.4%-
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Assets
Current Assets
Cash and Cash Equivalents$968K$8M$6.47M$5.47M$17.05M$8.09M$3.5M$2.57M$521K$951K$7.7M$2.1M$185K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$968K$8M$6.47M$5.47M$17.05M$8.09M$3.5M$2.57M$521K$951K$7.7M$2.1M$185K
Accounts Receivable$1.7M$1.65M$2.18M$2.47M$2.14M$4.56M$1.69M$1M$469K$305K$59K$1.25M$0
Inventory$8.6M$10.35M$9.19M$7.02M$4.9M$2.78M$2.13M$3.34M$2.07M$413K$230K$198K$0
Other Current Assets$9.08M$12.2M$10.12M$7.36M$0$0$941K$6K$239K$584K$143K$2.57M$4K
Total Current Assets$20.34M$32.2M$27.96M$22.32M$28.43M$17.79M$9.52M$8.15M$3.8M$2.56M$8.45M$4.88M$289K
Long-Term Assets
Property, Plant & Equipment Net$1.46M$1.4M$1.67M$1.7M$1.73M$677K$710K$761K$1.22M$886K$829K$873K$0
Goodwill$0$0$0$0$0$0$0$0$5.21M$0$0$0$0
Intangible Assets$16.02M$18.48M$20.12M$22.44M$22.65M$24.34M$26.02M$31.71M$33.4M$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$3M$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$494K$1.35M$1.01M$995K$446K$37K$154K$421K$0$122K$122K$0$0
Total Long-Term Assets$17.98M$21.23M$22.8M$25.13M$24.83M$25.05M$26.89M$32.89M$39.83M$1.01M$3.95M$873K$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$38.32M$53.42M$50.76M$47.45M$53.27M$42.84M$36.41M$41.04M$43.63M$3.56M$12.41M$5.76M$289K
Liabilities
Current Liabilities
Accounts Payable$8.69M$5.29M$4.97M$5.81M$4.93M$4.76M$5.35M$5.41M$7.35M$517K$574K$698K$9K
Short-Term Debt$27.44M$12.04M$4.87M$15.88M$3.18M$3.79M$6.78M$16.08M$5.42M$2.07M$1.86M$817K$519K
Current Income Tax Payable$0$114K$292K$585K$510K$127K$241K$153K$71K$20K$44K$0$0
Current Unearned Revenue$170K$170K$0$0$0$0$0$4.94M$177K$224K$252K$24K$0
Other Current Liabilities$0$0$0$0$1K$179K$3K$374K$2.17M$1.16M$469K-$88K$116K
Total Current Liabilities$40.65M$19.7M$13.99M$30.34M$15.47M$13.22M$15.39M$26.66M$15.39M$4.19M$3.91M$2.79M$724K
Long-Term Liabilities
Long-Term Debt$15.08M$23.5M$30.99M$17.74M$25.02M$12.42M$450K$0$10.98M$1.82M$4.1M$0$0
Long-Term Unearned Revenue$382K$553K$0$0$0$0$0$0$0$0$3K$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0-$3K$0$0
Other Long-Term Liabilities$0$2.48M$0$0$0$0$9.89M$0$0$7K$3K$1.88M$0
Total Long-Term Liabilities$16.36M$27.23M$31.88M$18.47M$25.94M$12.42M$10.35M$9M$10.98M$1.82M$4.1M$1.88M$528K
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0-$528K
Total Liabilities$57.01M$46.93M$45.87M$48.81M$41.41M$25.64M$25.74M$35.66M$26.37M$6.02M$8.01M$4.66M$724K
Stockholders' Equity
Preferred Stock$2.48M$0$0$0$0$0$1.71M$9T$43.63T$3.56T$12.41B$0$0
Common Stock$1K$0$0$0$5K$4K$5K$6K$11K$1K$812$525$267
Retained Earnings-$399.92M-$346.48M-$308.25M-$266.95M-$219.49M-$166.9M-$133.09M-$94.55M-$62.4M-$40.44M-$25.7M-$11.09M-$801K
Comprehensive Income & Other-$833K-$467K-$652K-$680K$0$0$0-$9T-$43.63T-$3.56T-$12.41B$0$0
Other Stockholders' Equity$382.63M$353.77M$313.21M$266.29M$231.1M$184.1M$143.76M$99.93M$79.66M$37.98M$30.1M$12.18M$366K
Total Equity-$17.29M$7.29M$4.96M-$657K$11.61M$17.2M$10.67M$5.38M$17.26M-$2.45M$4.4M$1.1M-$435K
Minority Interest-$1.4M-$791K-$64K-$699K$242K$0$0$0$0$0$0$0$0
Total Liabilities and Equity$39.72M$54.22M$50.83M$48.15M$53.02M$42.84M$36.41M$41.04M$43.63M$3.56M$12.41M$5.76M$289K
Supplementary Data
Total Debt$43.61M$36.53M$37.09M$34.84M$29.36M$16.21M$7.57M$16.08M$16.41M$3.89M$5.95M$729K$519K
Net Debt$42.64M$28.52M$30.63M$29.37M$12.31M$8.12M$4.07M$13.52M$15.88M$2.94M-$1.74M-$1.37M$334K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Operating Activities
Net Income-$15.37M-$39.03M-$41.87M-$49.08M-$52.6M-$33.81M-$38.54M-$32.15M-$21.97M-$14.73M-$16.29M-$8.61M
Depreciation & Amortization$2.2M$2.36M$2.39M$2.29M$1.81M$2.28M$1.93M$1.32M$584K$47K$5K$0
Deferred Income Tax$0$0$0$0$4.39M$0$0$5.75M-$13.18M$151K$536K$0
Stock-Based Compensation-$810K$1.64M$2.11M$3.32M$3.97M$2.82M$2.99M$2.02M$815K$718K$992K$164K
Changes in Working Capital:
  Accounts Receivable-$434K$526K$298K-$170K$2.82M-$2.87M-$704K-$528K-$166K$51K-$56K$1.09M
  Inventory$902K-$1.16M-$2.17M-$2.12M-$2.12M-$653K$1.21M-$1.27M$128K-$183K-$32K-$198K
  Accounts Payable$3.02M$328K-$855K$902K$158K-$743K-$63K-$1.94M$4.19M-$28K-$240K$689K
  Other Working Capital$9.4M-$2.71M-$8.38M-$3.04M$1.4M$795K-$1.11M$2.81M-$23K-$986K-$1.96M$24K
Total Working Capital Change$12.89M-$3.01M-$11.1M-$4.43M$2.27M-$3.47M-$662K-$925K$4.13M-$1.15M-$2.28M$1.6M
Other Non-Cash Items$6.89M$8.66M$15.23M$14.79M$5.19M$16.89M$13.83M$1.25M$19.8M$549K$2.73M$1.38M
Net Cash from Operating$5.8M-$29.38M-$33.24M-$33.1M-$34.97M-$15.28M-$20.46M-$22.73M-$9.82M-$14.41M-$14.32M-$5.46M
Investing Activities
Capital Expenditures-$25K-$16K$0-$77K-$6K-$7K$0-$7K$0-$104K-$23K-$55K
Acquisitions$0$0$0$0$247K$0$0$0-$1.56M$0$21K$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0-$3M$0
Sales of Investments$0$0$0$0$0$0$0$0$0$3M$0$0
Other Investing Activities$174K-$215K$0-$1.6M-$247K$0$0-$7K$272K$2.49M-$2.98M$0
Net Cash from Investing$149K-$231K$0-$1.68M-$6K-$7K$0-$7K-$1.29M$2.38M-$3M-$55K
Financing Activities
Debt Repaid$20.91M$100K$100K-$3.88M-$9.05M-$5.69M$100K-$876K-$378K$2.49M-$4.52M-
Common Stock Issuance$1.86M$31.91M$32.1M$20.46M$33.58M$1.95M$6.63M$16.68M$10.3M$8.83M$18.81M$0
Common Stock Repurchases-$31.07M$0$0$0$0$0$0-$30$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$44K-$608K$1.62M-$1.16M$1.31M$11.86M$9.23M-$2.12M$0-$1.06M-$405K-$2.38M
Net Cash from Financing-$44.33M$31.2M$34.23M$23.18M$43.94M$19.49M$21.77M$24.55M$10.68M$5.28M$24.17M$6.18M
Forex Effect-$59K-$54K$15K$16K$0$0$0$0$0$0$0$0
Net Change in Cash-$38.35M$1.53M$1M-$11.58M$8.96M$4.21M$1.31M$1.81M-$430K-$6.75M$6.85M$660K
Supplementary Data
Operating Cash Flow$5.8M-$29.38M-$33.24M-$33.1M-$34.97M-$15.28M-$20.46M-$22.73M-$9.82M-$14.41M-$14.32M-$5.46M
Capital Expenditure-$25K-$231K$0-$1.68M-$6K-$7K$0-$7K$0-$104K-$23K-$55K
Free Cash Flow$5.77M-$29.61M-$33.24M-$34.78M-$34.98M-$15.29M-$20.46M-$22.74M-$9.82M-$14.52M-$14.34M-$5.52M
Cash at Beginning$46.19M$6.47M$5.47M$17.05M$8.09M$3.88M$2.57M$760K$951K$7.7M$845K$185K
Cash at End$7.83M$8M$6.47M$5.47M$17.05M$8.09M$3.88M$2.57M$521K$951K$7.7M$845K